California Nanotechnologies is trading 12.25% up at $0.31 after reporting Q2 fiscal 2027 results on October 27, 2026. - Revenue rose 23% year over year to US$956,794; adjusted EBITDA improved 56% year over year. - The quarter recorded a US$359,148 net loss and diluted loss per share of US$0.02. The company secured more than US$2.5 million in purchase orders during Q3/FY2027. - The release did not explicitly link the results to the share-price move; trading volume was not reported in the release.